AR108783A1 - IONIC LIQUIDS OF TRIALQUILFOSFONIO, METHODS TO OBTAIN THEM AND RENTAL PROCESSES THAT USE IONIC LIQUIDS OF TRIALQUILFOSFONIO - Google Patents

IONIC LIQUIDS OF TRIALQUILFOSFONIO, METHODS TO OBTAIN THEM AND RENTAL PROCESSES THAT USE IONIC LIQUIDS OF TRIALQUILFOSFONIO

Info

Publication number
AR108783A1
AR108783A1 ARP170101562A ARP170101562A AR108783A1 AR 108783 A1 AR108783 A1 AR 108783A1 AR P170101562 A ARP170101562 A AR P170101562A AR P170101562 A ARP170101562 A AR P170101562A AR 108783 A1 AR108783 A1 AR 108783A1
Authority
AR
Argentina
Prior art keywords
trialquilfosfonio
ionic liquids
methods
trialkylphosphonium
compound
Prior art date
Application number
ARP170101562A
Other languages
Spanish (es)
Inventor
Douglas Andrew Nafis
Susie C Martins
Avram Michael Buchbinder
Donato Nucciarone
Original Assignee
Cytec Ind Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cytec Ind Inc filed Critical Cytec Ind Inc
Publication of AR108783A1 publication Critical patent/AR108783A1/en

Links

Abstract

Un compuesto de haloaluminato de trialquilfosfonio que tiene una fórmula (1), donde R¹ R² y R³ son iguales o diferentes y cada uno se selecciona de forma independiente entre C₁ y C₈ hidrocarbilo; y X se selecciona entre F, Cl, Br, I o combinaciones de estos. También se describe una composición catalizadora de líquido iónico que incorpora el compuesto de haloaluminato trialquilfosfonio, métodos para obtener el compuesto de haloaluminato de trialquilfosfonio y procesos de alquilación que incorporan el compuesto de haloaluminato de trialquilfosfonio, además cuando X es Cl, R¹, R² y R³ no son todos metilo.A trialkylphosphonium haloaluminate compound having a formula (1), where R¹R² and R³ are the same or different and each is independently selected from C₁ and C₈ hydrocarbyl; and X is selected from F, Cl, Br, I or combinations thereof. An ionic liquid catalyst composition is also described which incorporates the trialkylphosphonium haloaluminium compound, methods for obtaining the trialkylphosphonium haloaluminate compound and alkylation processes incorporating the trialkylphosphonium haloaluminate compound, in addition when X is Cl, R¹, R² and R³ They are not all methyl.

ARP170101562A 2016-06-07 2017-06-07 IONIC LIQUIDS OF TRIALQUILFOSFONIO, METHODS TO OBTAIN THEM AND RENTAL PROCESSES THAT USE IONIC LIQUIDS OF TRIALQUILFOSFONIO AR108783A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201662346831P 2016-06-07 2016-06-07

Publications (1)

Publication Number Publication Date
AR108783A1 true AR108783A1 (en) 2018-09-26

Family

ID=62639057

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP170101562A AR108783A1 (en) 2016-06-07 2017-06-07 IONIC LIQUIDS OF TRIALQUILFOSFONIO, METHODS TO OBTAIN THEM AND RENTAL PROCESSES THAT USE IONIC LIQUIDS OF TRIALQUILFOSFONIO

Country Status (2)

Country Link
AR (1) AR108783A1 (en)
TW (1) TW201811431A (en)

Also Published As

Publication number Publication date
TW201811431A (en) 2018-04-01

Similar Documents

Publication Publication Date Title
EA201990017A1 (en) ANTIBODIES TO MYOSTATIN AND WAYS OF THEIR APPLICATION
CO2018002703A2 (en) Anti-promiostatin or latent myostatin antibodies and uses thereof
CO2017005842A2 (en) Heterodimeric antibodies that bind to cd3 and cd38
EA201791253A1 (en) ANTIBODIES TO MYOSTATIN, POLYPEPTIDES, CONTAINING OPTIONS OF FC-REGIONS, AND METHODS OF THEIR APPLICATION
CL2019001735A1 (en) Anti-alpha-synuclein monoclonal antibodies to prevent tau aggregation.
CL2017001408A1 (en) Anti-cd79b antibodies and methods of use
EA201890866A1 (en) BINDING MOLECULES THAT INHIBIT CANCER GROWTH
AR111288A1 (en) ANTI-PHF-TAU ANTIBODIES AND ITS USES
CL2015002529A1 (en) Tetrahydropyrrolothiazine Compounds
EA201991598A1 (en) COMPOUNDS MODULATING THE Aryl Hydrocarbon Receptor (AhR)
TR201900038T4 (en) Tetrahydropyridopyrazine modulators of GPR6.
AR099677A1 (en) FUSION HETEROCYCLIC COMPOUND AND ITS USE FOR PEST CONTROL
CU24435B1 (en) COMPOUND OF (PYRAZOLYLAMINE) PYRIMIDINYL BICYCLE (3.2.1) OCT-8-IL
AR090868A1 (en) PESTICIDED COMPOSITIONS AND PROCESSES RELATED TO THEM
CL2016002798A1 (en) Compounds derived from nitrogenous tricycles containing a naphthyridine condensed with a benzimidazole and its use as inhibitors of cell proliferation for the treatment of lung, colorectal, liver, pancreas, lymph node, colon, prostate, brain, head and neck, skin cancer , kidney blood or heart.
AR097866A1 (en) 4-AZAINDOL DERIVATIVES
BR112015021540A2 (en) processes for preparing an apoptosis inducing agent
EA201690958A1 (en) DEPRESSANTS FOR USE IN DIVISION METHODS
CL2019001381A1 (en) Method for the treatment of focal segmental glomerulosclerosis.
EA201790587A1 (en) GEOPOSITIONING USING DIRECTIONAL SURFACE WAVES
EA201990159A1 (en) BIARYLMETHyl HETEROCYCLES
AR100144A2 (en) QUATERNARY PHOSPHONE HALOALUMINATE COMPOUNDS
AR104262A1 (en) CHROMENE DERIVATIVES AS INHIBITORS OF PHOSFOINOSITIDO-3 KINASES
AR095040A1 (en) H3 ANTAGONISTS CONTAINING A STRUCTURAL CORE OF PHENOXIPIPERIDINE
AR101290A1 (en) ALDOSTERONE SINTASA INHIBITORS

Legal Events

Date Code Title Description
FB Suspension of granting procedure